Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Pharmaceutical Specialties Based On Eculizumab And Ravulizumab

Healthcare Public Procurement (HeCaPP) Belgium has Released a tender for Pharmaceutical Specialties Based On Eculizumab And Ravulizumab in Pharmaceuticals. The tender was released on Aug 04, 2025.

Country - Belgium

Summary - Pharmaceutical Specialties Based On Eculizumab And Ravulizumab

Deadline - Sep 18, 2025

GT reference number - 114893974

Product classification - Pharmaceutical products

Organization Details:

  Address - Belgium

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 114893974

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: New patients will be subject to this public market, patients currently under treatment must not be changed. The doctor will keep the possibility of using the molecule best suited to the patient's needs.local title:: Spécialités pharmac eutiques à base de ECULIZUMAB et de RAVULIZUMABContract Duration: : 365 DAYContract Type: : Supplylocal description: : Les nouveaux patients feront l’objet de ce marché public, les patients actuellement sous traitement ne doivent pas obligatoirement en changer. Le médecin gardera la possibilité d’utiliser la molécule la mieux adaptée aux besoins du patient. lot_details: 1: Pharmaceutical specialty based on Eculizumab or Ravulizumab, 2:

Gt Ref Id - 114893974

Deadline - Sep 18, 2025

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database